You are here

Policy

 

The Joint Commission has announced it will not move forward in implementing any of its proposed changes to accreditation standards.

Don Rucker, MD, head of the Office of the National Coordinator for Health IT (ONC) said his agency has been focused on improving usability and interoperability of electronic health records, adding that while blockchain technology may provide some interesting capabilities but it’s too soon to issue regulations on it.

A study published in JMIR mHealth and uHealth includes a list of five recommendations for improving mHealth utilization for adolescents with chronic conditions. The researched aimed at improving disease self-management in adolescents by utilizing mHealth technology for real-time care.

While clinicians may be confused or frustrated with the Medicare Access and CHIP Reauthorization Act (MACRA), professionals in health information management should see it as “nothing but positive” and embrace it, according to Bonnie Cassidy, MPA, principal of advisory services at nThrive and former president and chair of the American Health Information Management Association (AHIMA).

Embracing artificial intelligence (AI) technology is “a necessity” for the health IT industry, according to Harold “Hal” Wolf III, the next president and CEO of the Healthcare Information and Management Systems Society (HIMSS).

 

Recent Headlines

HHS announces grants for rural telehealth training to fight opioid abuse

Three states will receive $9 million in grants to help train rural physicians in efforts to fight opioid addiction, HHS announced at the meeting of the National Governors Association.

Joint Commission keeping clinician texting ban in place until September

After reversing a five-year-old ban on healthcare organizations sending orders in May, the Joint Commission has changed plans again, announcing in its June newsletter the previous ban won’t be lifted until September.

House panel debates greater FDA role in regulating health apps

The safety, effectiveness and data security of mobile healthcare applications were examined by a U.S. House subcommittee in a July 13 hearing, with lawmakers alternating between excitement over their potential and concern that consumers’ data isn’t being protected.

21st Century Cures Act won’t get Senate vote before long recess

It’s been more than a year since the House passed the 21st Century Cures Act, which aims to speed up regulatory approval for medical devices and drugs, but the Senate’s chief advocate for the legislation said it’ll be at least another seven weeks before its put up for a vote.

HHS issues new guidance on ransomware attacks

HHS’ Office of Civil Rights (OCR) has released its much-anticipated guidance on how healthcare organizations can better understand and respond to ransomware attacks, including defining such incidents as breaches that require affected individuals to be notified under HIPAA in most circumstances.

FDA-approved stomach-draining device may face lawsuit

The Food and Drug Administration has approved several new weight loss interventions in the past year, but one in particular seems to be raising eyebrows among physicians.

Nearly 600 U.S. clinics could be selling unregulated stem cell treatments

The risks of “stem cell tourism” might be overplayed, according to a new paper published June 30 in the journal Cell Stem Cell. But only because the real risks of unregulated stem cells might actually be within the U.S.

 
Biden rallies participants to double cancer progress in 'moonshot' kick-off

Vice President Joe Biden led a major step toward completing his “moonshot” task of curing cancer June 29, when he spoke at the first Cancer Moonshot Summit.

 
FDA approves test for quicker detection of hospital ‘superbugs’

The Food and Drug Administration (FDA) has given a thumbs up to a test hospitals can use to identify certain types of antibiotic-resistant infections more quickly.

Study reveals differing standards for approval of American, European medical devices

Medical devices play a vital role in patient care, but how they are approved and regulated are vastly different in the United States compared to the European Union.

Pages